Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 236 publications
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor.
Journal: Journal of medicinal chemistry
Published: February 09, 2026
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Journal: Nature medicine
Published: January 29, 2026
Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource.
Journal: Nature
Published: July 31, 2025
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction.
Journal: Science (New York, N.Y.)
Published: July 04, 2024
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Journal: Nature medicine
Published: May 30, 2024
Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
Journal: Nature medicine
Published: February 21, 2024
Author Correction: Diversity-oriented synthesis encoded by deoxyoligonucleotides.
Journal: Nature communications
Published: November 21, 2023
High-throughput approaches to uncover synergistic drug combinations in leukemia.
Journal: SLAS discovery : advancing life sciences R & D
Published: November 29, 2022
Diversity-oriented synthesis encoded by deoxyoligonucleotides.
Journal: Nature communications
Published: October 25, 2022
Bridging the Gap to Translating Genome-Wide Discoveries Into Therapies to Prevent and Treat Atherosclerotic Cardiovascular Disease.
Journal: Circulation
Published: September 19, 2022
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy.
Journal: Cell chemical biology
Published: June 11, 2022
Last Updated: 09/26/2026